About 19,100 results
Open links in new tab
  1. Official Patient Website | Tecfidera® (dimethyl fumarate)

    Discover Tecfidera® (dimethyl fumarate), a twice-daily pill for relapsing MS. Learn about efficacy, and see important Safety Information.

  2. Tecfidera for MS: Uses, Dosage & Side Effects - Drugs.com

    Aug 9, 2024 · Tecfidera (dimethyl fumarate) is used to treat relapsing forms of multiple sclerosis (MS) to help you have fewer relapses, delay the progression of disability, and slow brain lesion …

  3. Tecfidera (dimethyl fumarate) for multiple sclerosis

    Jun 12, 2025 · What is Tecfidera for MS? Tecfidera (dimethyl fumarate) is an approved oral therapy indicated for adults with relapsing forms of multiple sclerosis (MS), including clinically isolated …

  4. Dimethyl Fumarate (Tecfidera) - Uses, Side Effects, and More

    Dec 20, 2024 · Overview: Dimethyl fumarate is used to treat multiple sclerosis. Common side effects include flushing and stomach problems, such as stomach pain, nausea, and diarrhea. You can take …

  5. Tecfidera: Side effects, for MS, dosage, and more

    Aug 18, 2025 · Tecfidera (dimethyl fumarate) is a prescription drug used for clinically isolated syndrome and certain forms of MS. Learn about side effects and more.

  6. Tecfidera (Dimethyl Fumarate Delayed Release Capsules): Side ... - RxList

    Mar 22, 2024 · Tecfidera (Dimethyl Fumarate Delayed Release Capsules) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug …

  7. How should I take TECFIDERA? • Take TECFIDERA exactly as your doctor tells you to take it 2 times a day for 7 days • The recommended dose after 7 days is one 240 mg capsu • TECFIDERA can be …

  8. Tecfidera: Uses, Taking, Side Effects, Warnings - Medicine.com

    Tecfidera is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive …

  9. Multiple Sclerosis - Medical Clinical Policy Bulletins | Aetna

    Aetna considers concomitant use of alemtuzumab (Lemtrada), cladribine (Mavenclad), dimethyl fumarate (Tecfidera), fingolimod (Gilenya), glatiramer acetate (Copaxone, Glatopa), interferon beta, …

  10. Tecfidera: Package Insert / Prescribing Information / MOA

    Jun 12, 2025 · Tecfidera package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.